Bluebird Ventures is a life sciences venture capital firm focused on innovative biotechnology and therapeutic platforms. The firm invests in companies advancing genetic medicines, precision diagnostics, and next-generation treatment modalities.
Its portfolio includes multiple late-stage and growth financings across gene therapy, molecular diagnostics, and RNA technologies. Bluebird Ventures frequently participates in repeat rounds, supporting companies from early clinical development through expansion stages.
Notable investments include Foresight Diagnostics, Procyrion, Kriya Therapeutics, Leyden Labs, and Nutcracker Therapeutics, spanning Series A through late-stage growth rounds.
People
- Jeff Bird, Managing Director
You last contacted this investor on .